Array cancer drug gets FDA's breakthrough therapy designation
Boulder-based pharmaceutical firm Array BioPharma Inc. has received the U.S. Food and Drug Administration's breakthrough therapy designation for an investigational drug combination to treat colorectal cancer, according to a company news release.
from Biotech News
0 Comments